Reach further, in an Open Access Journal Endocrinology, Diabetes & Metabolism Case Reports

ISSN 1470-3947 (print)
ISSN 1479-6848 (online)

Searchable abstracts of presentations at key conferences in endocrinology

Published by BioScientifica
Endocrine Abstracts (2010) 22 P735 

Effect of body mass index on differences of sex hormone levels in postmenopausal women receiving low-dose hormone therapy

Irene Lambrinoudaki1, Eleni Armeni1, Demetrios Rizos2, Panagiotis Kofinakos1, George Kaparos2, Andreas Alexandrou3, Maria Creatsa1, Emanuel Logothetis2, Dimitra Papadimitriou1, Efstratios Tsakonas1 & Evangelia Kouskouni2

Author affiliations

Objective: To investigate the effect of BMI on the absolute change from baseline levels in circulating sex hormone in postmenopausal women treated with oral continuous combined low dose HT for 6 months.

Design: The study recruited 36 postmenopausal women who received daily E2 1 mg/NETA 0.5 mg for 6 months. Hormonal assessment included measures of serum concentrations of FSH, LH, 17β-estradiol and free estrogen index (FEI), total and free testosterone (FAI), Δ4-Androstendione, SHBG and DHEA-S before treatment and after 6 months of treatment. We compared percental changes of hormone levels from baseline and mean absolute hormone concentrations between lean and overweight women.

Results: Lean subjects had statistically significant higher increments of FEI compared to overweight (lean women: 0.1±0.09 at baseline, and 0.3±0.1 at final levels, Δ=181%; overweight women: 0.2±0.1 at baseline, and 0.4±0.3 at final levels, Δ=87%, P=0.034). Mean 17β-estradiol increased in both groups at statistical significant levels (lean women: 22.4±12.0 pg/ml at baseline, and 45.9±20.7 pg/ml at final levels, Δ=105%, P=0.006; overweight women: 22.4±8.7 pg/ml at baseline 58.4±23.4 pg/ml at final levels, Δ=161%, P=0.0001; P(Δ%) between groups=0.619). Mean levels of FSH decreased significantly in both groups (lean women: Δ=−45%, P=0.0001; overweight women: Δ=–39%, P=0.003; P(Δ%) between groups=0.661).

Conclusions: Concentrations of free estrogens increase more sharply in lean women being under treatment with oral low-dose HT. BMI did not influence the changes of total 17β-estradiol levels from baseline. This finding might in part explain the vulnerability of lean women under HT to develop breast cancer.

This Issue/Conference

Article tools

My recent searches